Technology
Enterome’S Immunotherapy EO2463 Shows Early Clinical Response In Newly Diagnosed Follicular Lymphoma Suggesting A Potential Alternative To 'Watchful Waiting'
(MENAFN - GlobeNewsWire - Nasdaq) 46% objective response rate, with 15% complete responses and 31% partial responses in patients with early-stage follicular lymphoma reported at the ASH 2024 ...
By: menafn
- Dec 10 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS